Aligning Patient and Clinician Goals to Improve the Care of Ovarian Cancer

Overview

Release date: August 31, 2023
Expiration date: August 31, 2024
Estimated time to complete activity: 45 minutes

PROVIDER STATEMENT

This educational activity is provided by Integrity Continuing Education, Inc.

DISCLOSURE OF COMMERCIAL SUPPORT

This educational activity is supported by educational grants from AstraZeneca Pharmaceuticals, GSK, and Merck Sharp & Dohme LLC. 

PROGRAM OVERVIEW

Ovarian cancer is a less common type of cancer but one of the deadliest. Diagnoses at a more advanced stage are typical and associated with significantly worse outcomes. Poor outcomes are exacerbated by healthcare disparities associated with ovarian cancer and patient-reported communication challenges. 

A series of three succinct clinical cases – written by a practicing gynecologic oncologist – will allow you to choose appropriate testing, select treatment, and assess adverse events, with insight and guidance on decisions and management provided by expert faculty after each case. 

Join ovarian cancer experts Martina Murphy, MD, Eleonora Teplinksy, MD, and Mollie Finkel, RN, MSN, WHNP-BC, AOCNP-BC as they address the ongoing disparities in care, strategies to improve communication between patients and their healthcare team, and patient management.

FACULTY CO-CHAIRS

Martina C. Murphy, MD  
Associate Professor of Medicine  
Program Director, Hematology/Oncology Fellowship 
University of Florida  
Assistant Director, Clinical Research Education & Professional Development
Medical Director, Communication Strategies & Digital Innovation
University of Florida Health Cancer Center
Gainesville, Florida 

Eleonora Teplinsky, MD
Head, Breast Medical Oncology 
Clinical Assistant Professor of Medicine 
Icahn School of Medicine at Mount Sinai 
Paramus, New Jersey 

Mollie Finkel, RN, MSN, WHNP-BC, AOCNP-BC
Clinical Program Director of GYN Oncology
Mount Sinai Health System
New York, New York

CLINICAL CASE DEVELOPMENT FACULTY

Megan Hutchcraft, MD 
Gynecologic Oncologist 
Carle Cancer Institute 
Assistant Clinical Professor 
Carle Illinois College of Medicine 
University of Illinois at Urbana-Champaign 
Champaign, Illinois 

TARGET AUDIENCE

This activity is designed to meet the professional educational needs of gynecologic and medical oncologists, as well as other clinicians involved in the treatment and management of patients with ovarian cancer. 

LEARNING OBJECTIVES

Upon completion of this educational activity, participants should be able to:

• Apply current guideline recommendations for genetic testing and treatment to improve the health outcomes of women with epithelial ovarian cancer  
• Identify key clinical trial information that can be utilized in the treatment decision-making process (endpoints, patient population, outcomes, adverse event profile, etc) 
• Identify tools to improve clinician-patient communication and the care of women with epithelial ovarian cancer

DIRECTIONS TO LEARNER

There are no fees for participating and receiving CME credit for this activity. During the period of August 31, 2023 through August 31, 2024, participants must:

• Read the learning objectives and faculty disclosures
• Complete the pretest
• Study the educational activity
• Complete the posttest and the evaluation form

A statement of credit will be issued only upon receipt of a completed posttest with a score of 66% or better and a completed activity evaluation form.

MEDIA

Internet

ACCREDITATION STATEMENT

Integrity Continuing Education, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CREDIT DESIGNATION

Integrity Continuing Education, Inc. designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CONTACT INFORMATION

For information about ACCME accreditation of this activity, please contact Integrity Continuing Education, Inc. at (855) 835-4004 or cme@integrityce.com.

DISCLOSURE OF CONFLICTS OF INTEREST

Integrity Continuing Education, Inc. requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any financial relationships with ineligible companies. All identified relevant financial relationships are thoroughly vetted by Integrity Continuing Education, Inc. for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. All relevant financial relationships have been mitigated.

The following faculty/planners reported the financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CME activity:

Mollie Finkel, RN, MSN, WHNP-BC, AOCNP-BC, does not have any financial relationships or relationships to products or devices with ineligible companies.

Megan Hutchcraft, MD does not have any financial relationships or relationships to products or devices with ineligible companies.  

Martina Murphy, MD does not have any financial relationships or relationships to products or devices with ineligible companies.

Eleonora Teplinsky, MD
Advisory Board: AstraZeneca
Medical Advisor: FloHealth, Sermo

The Integrity Continuing Education, Inc. planners and managers do not have any financial relationships or relationships to products or devices with ineligible companies.

DISCLOSURE OF UNLABELED USE

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Integrity Continuing Education, Inc. does not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

PRIVACY POLICY

When you participate in an online educational activity sponsored by Integrity Continuing Education, Inc., you will be asked for your name, degree(s), affiliation(s), street address, telephone number and…(continued)

MINIMUM SYSTEM REQUIREMENTS

Minimum Processor: Intel Pentium 4, 2.33 + GHz (or equivalent)
Operating Systems: Windows XP, Windows 2000, Windows Vista, Windows 7, Windows 10, and Mac OS
Plug-in: Adobe^® Flash^® Player 10
• Adobe^® Flash^® Player 10 plug-in should be downloaded
• Click on the “Agree and install now” button after unchecking the optional McAfee Security Scan Plus
For optimal performance, the use of Internet Explorer below 8 is not recommended

For a full listing of recommended operating systems, browsers, and system configurations, please click on the link below:
Click here for more information on minimum system requirements

DISCLAIMER

The information provided at this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition.